Dominant mutations in familial lethal and severe osteogenesis imperfecta
- 1 July 1991
- journal article
- case report
- Published by Springer Nature in Human Genetics
- Vol. 87 (3) , 297-301
- https://doi.org/10.1007/bf00200907
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Bone disease cracks geneticsNature, 1990
- The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen.Journal of Medical Genetics, 1990
- Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.Journal of Clinical Investigation, 1989
- A new lethal brittle bone syndrome with increased amount of type V collagen in a patientAmerican Journal of Medical Genetics, 1989
- A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.Journal of Clinical Investigation, 1989
- Osteogenesis imperfecta type IIA: evidence for dominant inheritance.Journal of Medical Genetics, 1987
- Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Osteogenesis imperfecta type III. Delineation of the phenotype with reference to genetic heterogeneityAmerican Journal of Medical Genetics, 1986
- Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneityAmerican Journal of Medical Genetics, 1984
- RECURRENCE RISK IN OSTEOGENESIS IMPERFECTA CONGENITAThe Lancet, 1980